These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21986572)

  • 1. Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.
    Sun XD; Shi XJ; Sun XO; Luo YG; Wu XJ; Yao CF; Yu HY; Li DW; Liu M; Zhou J
    Acta Pharmacol Sin; 2011 Dec; 32(12):1543-8. PubMed ID: 21986572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.
    Sun L; Sun X; Xie S; Yu H; Zhong D
    Biochem Biophys Res Commun; 2014 May; 447(3):465-70. PubMed ID: 24732354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
    Kaan HY; Ulaganathan V; Rath O; Prokopcová H; Dallinger D; Kappe CO; Kozielski F
    J Med Chem; 2010 Aug; 53(15):5676-83. PubMed ID: 20597485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor.
    Liu M; Yu H; Huo L; Liu J; Li M; Zhou J
    Biochem Pharmacol; 2008 Jul; 76(2):169-78. PubMed ID: 18539263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity.
    Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA
    Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5.
    Rello-Varona S; Vitale I; Kepp O; Senovilla L; Jemaá M; Métivier D; Castedo M; Kroemer G
    Cell Cycle; 2009 Apr; 8(7):1030-5. PubMed ID: 19270519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers.
    Murase Y; Ono H; Ogawa K; Yoshioka R; Ishikawa Y; Ueda H; Akahoshi K; Ban D; Kudo A; Tanaka S; Tanabe M
    Cancer Sci; 2021 Nov; 112(11):4641-4654. PubMed ID: 34510663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel EG5 inhibitors.
    Sarli V; Huemmer S; Sunder-Plassmann N; Mayer TU; Giannis A
    Chembiochem; 2005 Nov; 6(11):2005-13. PubMed ID: 16216042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5.
    Exertier P; Javerzat S; Wang B; Franco M; Herbert J; Platonova N; Winandy M; Pujol N; Nivelles O; Ormenese S; Godard V; Becker J; Bicknell R; Pineau R; Wilting J; Bikfalvi A; Hagedorn M
    Oncotarget; 2013 Dec; 4(12):2302-16. PubMed ID: 24327603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of adjuvant dimethylenastron, a mitotic Kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery.
    Lüke J; Nassar K; Lüke M; Tura A; Merz H; Giannis A; Grisanti S
    Curr Eye Res; 2010 Dec; 35(12):1090-8. PubMed ID: 20961218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monastrol inhibition of the mitotic kinesin Eg5.
    Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
    J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chemical tools for investigating human mitotic kinesin Eg5.
    Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
    Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors.
    Nagarajan S; Skoufias DA; Kozielski F; Pae AN
    J Med Chem; 2012 Mar; 55(6):2561-73. PubMed ID: 22309208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
    Wang CH; Qiao C; Wang RC; Zhou WP
    Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
    Chin GM; Herbst R
    Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening.
    Zhang W; Zhai L; Lu W; Boohaker RJ; Padmalayam I; Li Y
    Chem Biol Drug Des; 2016 Aug; 88(2):178-87. PubMed ID: 26864917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
    Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
    Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.